Corbus Pharmaceuticals Holdings, Inc. Weighted Average Number of Shares Outstanding, Basic and Diluted
Corbus Pharmaceuticals Holdings, Inc. (CRBP) reported Weighted Average Number of Shares Outstanding, Basic and Diluted of 125.26 million shares for the 3-month period ending 2022-06-30, per its 10-Q filed 2022-08-09.
Discontinued › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted · last filed 2022-08-09
- Corbus Pharmaceuticals Holdings, Inc. weighted average number of shares outstanding, basic and diluted for the quarter ending 2022-06-30 was 125.26M shares, a 7.64% increase year-over-year.
- Corbus Pharmaceuticals Holdings, Inc. weighted average number of shares outstanding, basic and diluted for the quarter ending 2022-03-31 was 125.24M shares, a 7.65% increase year-over-year.
- Corbus Pharmaceuticals Holdings, Inc. weighted average number of shares outstanding, basic and diluted for the quarter ending 2021-12-31 was 125.26M shares, a 43.28% increase year-over-year.
- Corbus Pharmaceuticals Holdings, Inc. weighted average number of shares outstanding, basic and diluted for the quarter ending 2021-09-30 was 125.21M shares, a 52.92% increase year-over-year.
- Corbus Pharmaceuticals Holdings, Inc. weighted average number of shares outstanding, basic and diluted for fiscal 2021 was 122.99M shares, a 57.41% increase from fiscal 2020.
- Corbus Pharmaceuticals Holdings, Inc. weighted average number of shares outstanding, basic and diluted for fiscal 2020 was 78.13M shares, a 22.28% increase from fiscal 2019.
- Corbus Pharmaceuticals Holdings, Inc. weighted average number of shares outstanding, basic and diluted for fiscal 2019 was 63.90M shares, a 12.10% increase from fiscal 2018.
- Corbus Pharmaceuticals Holdings, Inc. weighted average number of shares outstanding, basic and diluted for fiscal 2018 was 57.00M shares, a 13.60% increase from fiscal 2017.
| Period end | Weighted Average Number of Shares Outstanding, Basic and Diluted 3 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 6 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 9 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 12 month |
|---|---|---|---|---|
| 2022-06-30 | 125.26M shares 10-Q · filed 2022-08-09 | 125.25M shares 10-Q · filed 2022-08-09 | 125.25M shares derived: average of 3 quarters · filed 2022-08-09 | 125.24M shares derived: average of 4 quarters · filed 2022-08-09 |
| 2022-03-31 | 125.24M shares 10-Q · filed 2022-05-10 | 125.25M shares derived: average of 2 quarters · filed 2022-05-10 | 125.24M shares derived: average of 3 quarters · filed 2022-05-10 | 123.02M shares derived: average of 4 quarters · filed 2022-08-09 |
| 2021-12-31 | 125.26M shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-08 | 125.23M shares derived: average of 2 quarters · filed 2022-03-08 | 122.28M shares derived: average of 3 quarters · filed 2022-08-09 | 122.99M shares 10-K · filed 2022-03-08 |
| 2021-09-30 | 125.21M shares 10-Q · filed 2021-11-12 | 120.79M shares derived: average of 2 quarters · filed 2022-08-09 | 122.23M shares 10-Q · filed 2021-11-12 | 111.33M shares derived: average of 4 quarters · filed 2022-08-09 |
| 2021-06-30 | 116.36M shares 10-Q · filed 2022-08-09 | 120.72M shares 10-Q · filed 2022-08-09 | 106.71M shares derived: average of 3 quarters · filed 2022-08-09 | 100.50M shares derived: average of 4 quarters · filed 2022-08-09 |
| 2021-03-31 | 116.34M shares 10-Q · filed 2022-05-10 | 101.88M shares derived: average of 2 quarters · filed 2022-05-10 | 95.21M shares derived: average of 3 quarters · filed 2022-05-10 | 89.88M shares derived: average of 4 quarters · filed 2022-05-10 |
| 2020-12-31 | 87.42M shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-08 | 84.65M shares derived: average of 2 quarters · filed 2022-03-08 | 81.06M shares derived: average of 3 quarters · filed 2022-03-08 | 78.13M shares 10-K · filed 2022-03-08 |
| 2020-09-30 | 81.88M shares 10-Q · filed 2021-11-12 | 77.88M shares derived: average of 2 quarters · filed 2021-11-12 | 75.04M shares 10-Q · filed 2021-11-12 | 72.43M shares derived: average of 4 quarters · filed 2021-11-12 |
| 2020-06-30 | 73.89M shares 10-Q · filed 2021-08-12 | 71.58M shares 10-Q · filed 2021-08-12 | 69.28M shares derived: average of 3 quarters · filed 2021-08-12 | 68.12M shares derived: average of 4 quarters · filed 2021-08-12 |
| 2020-03-31 | 69.27M shares 10-Q · filed 2021-05-13 | 66.98M shares derived: average of 2 quarters · filed 2021-05-13 | 66.20M shares derived: average of 3 quarters · filed 2021-05-13 | |
| 2019-12-31 | 64.68M shares derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-15 | 64.67M shares derived: average of 2 quarters · filed 2021-03-15 | 63.90M shares 10-K · filed 2021-03-15 | |
| 2019-09-30 | 64.66M shares 10-Q · filed 2020-11-09 | 63.64M shares 10-Q · filed 2020-11-09 | ||
| 2019-03-31 | 61.68M shares 10-Q · filed 2020-05-11 | 59.46M shares derived: average of 2 quarters · filed 2020-05-11 | 58.71M shares derived: average of 3 quarters · filed 2020-05-11 | 58.32M shares derived: average of 4 quarters · filed 2020-05-11 |
| 2018-12-31 | 57.25M shares derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-16 | 57.23M shares derived: average of 2 quarters · filed 2020-03-16 | 57.21M shares derived: average of 3 quarters · filed 2020-03-16 | 57.00M shares 10-K · filed 2020-03-16 |
| 2018-09-30 | 57.22M shares 10-Q · filed 2019-11-07 | 57.19M shares derived: average of 2 quarters · filed 2019-11-07 | 56.92M shares 10-Q · filed 2019-11-07 | 56.14M shares derived: average of 4 quarters · filed 2019-11-07 |
| 2018-06-30 | 57.16M shares 10-Q · filed 2018-08-08 | 56.76M shares 10-Q · filed 2018-08-08 | 55.78M shares derived: average of 3 quarters · filed 2019-05-09 | 54.39M shares derived: average of 4 quarters · filed 2019-05-09 |
| 2018-03-31 | 56.37M shares 10-Q · filed 2019-05-09 | 55.10M shares derived: average of 2 quarters · filed 2019-05-09 | 53.47M shares derived: average of 3 quarters · filed 2019-05-09 | 52.65M shares derived: average of 4 quarters · filed 2019-05-09 |
| 2017-12-31 | 53.83M shares 10-K · filed 2018-03-12 | 52.03M shares derived: average of 2 quarters · filed 2018-11-08 | 51.41M shares derived: average of 3 quarters · filed 2018-11-08 | 50.18M shares 10-K · filed 2019-03-12 |
| 2017-09-30 | 50.22M shares 10-Q · filed 2018-11-08 | 50.21M shares derived: average of 2 quarters · filed 2018-11-08 | 48.95M shares 10-Q · filed 2018-11-08 | 47.79M shares derived: average of 4 quarters · filed 2018-11-08 |
| 2017-06-30 | 50.19M shares 10-Q · filed 2018-08-08 | 48.30M shares 10-Q · filed 2018-08-08 | 46.97M shares derived: average of 3 quarters · filed 2018-08-08 | 46.18M shares derived: average of 4 quarters · filed 2018-08-08 |
| 2017-03-31 | 46.38M shares 10-K · filed 2018-03-12 | 45.37M shares derived: average of 2 quarters · filed 2018-05-10 | 44.84M shares derived: average of 3 quarters · filed 2018-05-10 | 43.32M shares derived: average of 4 quarters · filed 2018-05-10 |
| 2016-12-31 | 44.35M shares 10-K · filed 2018-03-12 | 44.07M shares derived: average of 2 quarters · filed 2018-03-12 | 42.29M shares derived: average of 3 quarters · filed 2018-03-12 | 41.14M shares 10-K · filed 2018-03-12 |
| 2016-09-30 | 43.78M shares 10-K · filed 2018-03-12 | 41.27M shares derived: average of 2 quarters · filed 2018-03-12 | 40.06M shares 10-Q · filed 2017-11-08 | 39.45M shares derived: average of 4 quarters · filed 2018-03-12 |
| 2016-06-30 | 38.75M shares 10-K · filed 2018-03-12 | 38.18M shares 10-Q · filed 2017-08-09 | 38.01M shares derived: average of 3 quarters · filed 2018-03-12 | 37.20M shares derived: average of 4 quarters · filed 2018-03-12 |
| 2016-03-31 | 37.61M shares 10-K · filed 2018-03-12 | 37.64M shares derived: average of 2 quarters · filed 2018-03-12 | 36.68M shares derived: average of 3 quarters · filed 2018-03-12 | 34.24M shares derived: average of 4 quarters · filed 2018-03-12 |
| 2015-12-31 | 37.67M shares derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-12 | 36.22M shares derived: average of 2 quarters · filed 2018-03-12 | 33.12M shares derived: average of 3 quarters · filed 2018-03-12 | 31.35M shares 10-K · filed 2018-03-12 |
| 2015-09-30 | 34.77M shares 10-Q · filed 2016-11-10 | 30.84M shares derived: average of 2 quarters · filed 2016-11-10 | 29.24M shares 10-Q · filed 2016-11-10 | 28.36M shares derived: average of 4 quarters · filed 2016-11-10 |
| 2015-06-30 | 26.90M shares 10-Q · filed 2016-08-12 | 26.43M shares 10-Q · filed 2016-08-12 | 26.23M shares derived: average of 3 quarters · filed 2016-08-12 | 26.06M shares derived: average of 4 quarters · filed 2016-08-12 |
| 2015-03-31 | 25.87M shares 10-Q · filed 2016-05-13 | 25.89M shares derived: average of 2 quarters · filed 2016-05-13 | 25.78M shares derived: average of 3 quarters · filed 2016-05-13 | 24.85M shares derived: average of 4 quarters · filed 2016-05-13 |
| 2014-12-31 | 25.91M shares derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-28 | 25.73M shares derived: average of 2 quarters · filed 2016-03-28 | 24.51M shares derived: average of 3 quarters · filed 2016-03-28 | 20.16M shares 10-K · filed 2016-03-28 |
| 2014-09-30 | 25.54M shares 10-Q · filed 2015-11-10 | 23.81M shares derived: average of 2 quarters · filed 2015-11-10 | 18.24M shares 10-Q · filed 2015-11-10 | 15.39M shares derived: average of 4 quarters · filed 2015-11-10 |
| 2014-06-30 | 22.07M shares 10-Q · filed 2015-08-13 | 14.53M shares 10-Q · filed 2015-08-13 | 12.00M shares derived: average of 3 quarters · filed 2015-08-13 | 10.74M shares derived: average of 4 quarters · filed 2015-08-13 |
| 2014-03-31 | 6.96M shares 10-Q · filed 2015-05-13 | 6.96M shares derived: average of 2 quarters · filed 2015-05-13 | 6.96M shares derived: average of 3 quarters · filed 2015-05-13 | |
| 2013-12-31 | 6.96M shares derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-10 | 6.96M shares derived: average of 2 quarters · filed 2015-02-10 | 6.96M shares 10-K · filed 2015-02-10 | |
| 2013-09-30 | 6.96M shares 10-Q · filed 2014-11-13 | 6.96M shares 10-Q · filed 2014-11-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B | |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |